Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Comparison of Body Hydration State in Hemodialysis Patients
The clinical trial evaluating body hydration state in hemodialysis patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of saquinavir in patients with chronic indinavir-associated nephrotoxicity; the study sta…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis [Phase 4]
Phase 4 trial evaluating the immunogenicity of a trivalent influenza vaccine in patients with chronic kidney disease undergoing hemodialysis…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis [Phase 1]
Phase 1 multiple-dose safety study of denosumab 120 mg in adults with severe chronic kidney disease, including those on dialysis, completed …
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Cardiac and Renal Disease Study (CARDS)
This document reports the completion of the CARDS trial evaluating atorvastatin in individuals with diabetes at risk for cardiovascular dise…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Influence of Renal Function on the Circadian Variation of Cardiac Troponin
Completed clinical trial from Maastricht University Medical Center evaluated how renal function influences the circadian variation of cardia…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Risk Factors for CV Disease in a Dialysis Cohort
This completed clinical trial study examines risk factors for cardiovascular disease in a dialysis patient cohort.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Study of Haemodialysis Patients Switching From Aranesp to Biosimilar
A completed clinical trial evaluating haemodialysis patients switching from Aranesp (darbepoetin alfa) to a biosimilar to assess outcomes af…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia
This document reports on an observational study of Mircera (methoxy polyethylene glycol-epoetin beta) in chronic kidney disease patients on …
-
FDA approval · 2016-02-04FDA Approved: PARICALCITOL — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s paricalcitol under its original application NDA207174 for the treatment of secondary hyperparathyroid…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Effects of the Low-level Laser Therapy (LLLT) on Muscle Strength (MS) of the Patients With Kidneys Failure (KF) [NA]
A completed clinical trial evaluated whether low-level laser therapy improves muscle strength in patients with chronic kidney disease.
-
CLINICAL_TRIALS withdrawal · 2016-02-02Clinical Trial Update: Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts [NA]
A clinical trial of paclitaxel-coated balloon catheters for treating dysfunctional arteriovenous fistulas and grafts has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients [Phase 3]
Phase 3 clinical trial update on treating autonomous hyperparathyroidism in post-renal transplant recipients; results completed with posted …
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Treatment Adhesion in Dialysis Patients Treated With Cinacalcet [Phase 4]
Phase 4 clinical trial update on adherence to cinacalcet therapy in dialysis patients with hyperparathyroidism and chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease [Phase 2]
Phase 2 trial update evaluating patiromer titration in heart failure patients with chronic kidney disease; results posted.
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study
Clinical trial update on risk stratification in end-stage renal disease from the ISAR study, relating to ESRD/CKD and cardiovascular outcome…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: The Clinical Effects of Korean Adapted APD in Automated Peritoneal Dialysis Patients [Phase 4]
This is a Phase 4 clinical trial update assessing the clinical effects of Korean Adapted Automated Peritoneal Dialysis in patients with chro…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: An Observational Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis
An observational study comparing case-managed versus non-case-managed initiation of hemodialysis in chronic kidney disease patients has comp…
-
CLINICAL_TRIALS withdrawal · 2016-01-20Clinical Trial Update: CSPPT- Chronic Kidney Diseases Study [Phase 4]
Phase 4 CSPPT Chronic Kidney Diseases Study has been withdrawn by the sponsor; the trial evaluated treatment in hypertensive patients with h…
-
CLINICAL_TRIALS research · 2016-01-20Clinical Trial Update: Effects by Omission of Bandage Over Exit Site
A clinical trial update examining the effects of omitting the bandage over the exit site in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients [Phase 4]
Phase 4 trial comparing calcium acetate oral solution to sevelamer carbonate tablets in hemodialysis patients to test equivalence; results p…
-
FDA approval · 2016-01-14FDA Approved: PARICALCITOL — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application (ANDA) for paricalcitol from Aurobindo Pharma Limited. This generic paricalcitol is used to treat …
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 [Phase 4]
A Phase 4 study evaluating the effects of phosphate binders on vascular health markers in chronic kidney disease patients (stages 3 and 4) h…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis
An observational study evaluating daily use of methoxy polyethylene glycol epoetin beta in peritoneal dialysis patients with renal impairmen…
-
FDA approval · 2016-01-13FDA Approved: PARICALCITOL — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's original application for generic paricalcitol (PARICALCITOL), a vitamin D analog used to treat secondary hyperparathyr…